Evidence map›Paper›PMID 29917326›Full record

ArticleThe journal of pathology. Clinical research2018

Replacement and desmoplastic histopathological growth patterns: A pilot study of prediction of outcome in patients with uveal melanoma liver metastases.

Raymond Barnhill, Peter Vermeulen, Sofie Daelemans, Pieter-Jan van Dam, Sergio Roman-Roman, Vincent Servois, Ilse Hurbain, Sophie Gardrat, Graça Raposa, André Nicolas and 7 more

Open access · goldAbstract read
In one paragraph

Article in The journal of pathology. Clinical research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 1 pooled it
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 1 synthesis or guideline pooled it, 65 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 2 countries.

Raymond BarnhillDepartment of Pathology, Institut Curie, Paris, France.ORCID 0000-0001-8086-8544
Peter VermeulenHistoGeneX, Antwerpen, Belgium.
Sofie DaelemansHistoGeneX, Antwerpen, Belgium.
Pieter-Jan van DamHistoGeneX, Antwerpen, Belgium.
Sergio Roman-RomanDepartment of Translational Research, Institut Curie, Paris, France.
Vincent ServoisDepartment of Radiology, Institut Curie, Paris, France.
Ilse HurbainInstitut Curie, PSL Research University, CNRS, Paris, France.
Sophie GardratDepartment of Pathology, Institut Curie, Paris, France.
Graça RaposaInstitut Curie, PSL Research University, CNRS, Paris, France.
André NicolasDepartment of Pathology, Institut Curie, Paris, France.
Rémi DendaleDepartment of Radiotherapy, Institut Curie Orsay, Paris, France.
Gaëlle PierronDepartment of Somatic Genetics, Institut Curie, Paris, France.
Laurence DesjardinsDepartment of Ophthalmology, Institut Curie, Paris, France.
Nathalie CassouxUniversity of Paris Réné Descartes Faculty of Medicine, Paris, France.
Sophie Piperno-NeumannDepartment of Medical Oncology, Institut Curie, Paris, France.
Pascale MarianiDepartment of Surgery, Institut Curie, Paris, France.
Claire LugassyDepartment of Translational Research, Institut Curie, Paris, France.
Institut Curie · FRUniversity of Antwerp · BECentre National de la Recherche Scientifique · FRDélégation Paris 5 · FR

Funding

French National Research Agency ANR-10-INSB-04French National Research Agency France-BioImaging, ANR-10-INSB-04
6 · The paper itself

Abstract

Up to 50% of uveal melanomas (UM) metastasise to the liver within 10 years of diagnosis, and these almost always prove rapidly fatal. As histopathological growth patterns (HGPs) of liver metastases of the replacement and desmoplastic type, particularly from colon and breast carcinoma, may import valuable biological and prognostic information, we have studied HGP in a series of 41 UM liver metastases originating from 41 patients from the period 2006-2017. Twenty patients underwent enucleation while 21 had radiation therapy. Analysis of UM by array comparative genomic hybridisation revealed: 25 (64%) patients with high risk (monosomy3/8q gain); 13 (33%) intermediate risk (M3/8normal or disomy3/8q gain); and 1 low risk (disomy3/8normal). The principal HGP was replacement in 30 (73%) cases and desmoplastic in 11 (27%) cases. Cases with replacement demonstrated striking vascular co-option/angiotropism. With the development of liver metastasis, only the replacement pattern, largest primary tumour diameter, and R2 (incomplete resection) status predicted diminished overall survival (OS; p < 0.041, p < 0.017, p < 0.047, respectively). On multivariate analysis, only HGP (hazard ratio; HR = 6.51, p = 0.008) and resection status remained significant. The genomic high-risk variable had no prognostic value at this stage of liver metastasis. Chi-square test showed no association of HGP with monosomy 3 or 8q gain. Eighteen of 41 (44%) patients are alive with disease and 23 (56%) patients died with follow-up ranging from 12 to 318 months (mean: 70 months, median: 47 months). In conclusion, we report for the first time the frequency of the replacement and desmoplastic HGPs in liver UM metastases resected from living patients, and their potential important prognostic value for UM patients, as in other solid cancers. These results may potentially be utilised to develop radiological correlates and therapeutic targets for following and treating patients with UM metastases.

Indexed as

AdultAgedComparative Genomic HybridizationFemaleHumansLiver NeoplasmsMaleMelanomaMiddle AgedPilot ProjectsPrognosisProgression-Free SurvivalSurvival RateUveal Neoplasmsangiotropismdesmoplastichistopathological growth patternslivermetastasisreplacementuveal melanomavascular co-option

Identifiers

PMID29917326
PMCPMC6174621
OpenAlexW2808936024

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.